A Toxic RNA Templates the Synthesis of its own Fluorogenic Inhibitor by Using a Bioorthogonal Tetrazine Ligation in Cells and Tissues

Expanded RNA repeats cause >30 incurable diseases. One approach to mitigate their toxicity is by using small molecules that assemble into potent, oligomeric species upon binding to the disease-causing RNA in cells. Herein, we show that the expanded repeat [r(CUG) exp ] that causes myotonic dystrophy type 1 (DM1) catalyzes the in situ synthesis of its own inhibitor using an RNA-templated tetrazine ligation in DM1 patient-derived cells. The compound synthesized on-site improved DM1-associated defects at picomolar concentrations, enhancing potency by 10,000-fold, compared to its parent compounds that cannot undergo oligomerization. A fluorogenic reaction is also described where r(CUG) exp templates the synthesis of its own imaging probe to enable visualization of the repeat in its native context in live cells and muscle tissue.